Intel dives on weak results, guidance

In this talk, Eli Lilly's CEO dives into the resolution of the weight loss drug shortage that has impacted many consumers. The conversation covers crucial issues like Intel's staggering drop in stock value and job cuts, alongside the FTC's inquiry into high grocery prices despite falling costs for retailers. Listeners gain insight into the shifting pharmaceutical landscape and its effect on the market, as well as the broader economic challenges currently facing various sectors.